---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015782"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:02:06.088757+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# eXoZymes increases CEO base salary to $450K, grants options and $250K bonus

## Summary
- CEO Michael Heltzen base salary raised to $450,000 annualized.
- Granted options to purchase 235,817 shares at $12.40 per share, vesting quarterly over 4 years.
- One-time bonus of $250,000 approved.
- Options vesting starts July 1, 2025; expires June 29, 2032.

## SEC filing metadata
- accession: 0001641172-25-015782
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000164117225015782/0001641172-25-015782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000164117225015782/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015782
- JSON: https://secwatch.observer/filing/0001641172-25-015782.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.